The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rheumatoid Arthritis Devices Market Research Report 2025
Synopsis
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
The global Rheumatoid Arthritis Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rheumatoid Arthritis Devices include Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Devices.
Report Scope
The Rheumatoid Arthritis Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rheumatoid Arthritis Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatoid Arthritis Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
Segment by Type
Implantable Joint Prostheses
Spinal Devices
Other
Segment by Application
Elderly
Young adults
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rheumatoid Arthritis Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
The global Rheumatoid Arthritis Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rheumatoid Arthritis Devices include Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Devices.
Report Scope
The Rheumatoid Arthritis Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rheumatoid Arthritis Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatoid Arthritis Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
Segment by Type
Implantable Joint Prostheses
Spinal Devices
Other
Segment by Application
Elderly
Young adults
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rheumatoid Arthritis Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rheumatoid Arthritis Devices Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis Devices
1.2 Rheumatoid Arthritis Devices Segment by Type
1.2.1 Global Rheumatoid Arthritis Devices Market Value Comparison by Type (2024-2030)
1.2.2 Implantable Joint Prostheses
1.2.3 Spinal Devices
1.2.4 Other
1.3 Rheumatoid Arthritis Devices Segment by Application
1.3.1 Global Rheumatoid Arthritis Devices Market Value by Application: (2024-2030)
1.3.2 Elderly
1.3.3 Young adults
1.4 Global Rheumatoid Arthritis Devices Market Size Estimates and Forecasts
1.4.1 Global Rheumatoid Arthritis Devices Revenue 2019-2030
1.4.2 Global Rheumatoid Arthritis Devices Sales 2019-2030
1.4.3 Global Rheumatoid Arthritis Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rheumatoid Arthritis Devices Market Competition by Manufacturers
2.1 Global Rheumatoid Arthritis Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rheumatoid Arthritis Devices Average Price by Manufacturers (2019-2024)
2.4 Global Rheumatoid Arthritis Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rheumatoid Arthritis Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rheumatoid Arthritis Devices, Product Type & Application
2.7 Rheumatoid Arthritis Devices Market Competitive Situation and Trends
2.7.1 Rheumatoid Arthritis Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rheumatoid Arthritis Devices Players Market Share by Revenue
2.7.3 Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rheumatoid Arthritis Devices Retrospective Market Scenario by Region
3.1 Global Rheumatoid Arthritis Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rheumatoid Arthritis Devices Global Rheumatoid Arthritis Devices Sales by Region: 2019-2030
3.2.1 Global Rheumatoid Arthritis Devices Sales by Region: 2019-2024
3.2.2 Global Rheumatoid Arthritis Devices Sales by Region: 2025-2030
3.3 Global Rheumatoid Arthritis Devices Global Rheumatoid Arthritis Devices Revenue by Region: 2019-2030
3.3.1 Global Rheumatoid Arthritis Devices Revenue by Region: 2019-2024
3.3.2 Global Rheumatoid Arthritis Devices Revenue by Region: 2025-2030
3.4 North America Rheumatoid Arthritis Devices Market Facts & Figures by Country
3.4.1 North America Rheumatoid Arthritis Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rheumatoid Arthritis Devices Sales by Country (2019-2030)
3.4.3 North America Rheumatoid Arthritis Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rheumatoid Arthritis Devices Market Facts & Figures by Country
3.5.1 Europe Rheumatoid Arthritis Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rheumatoid Arthritis Devices Sales by Country (2019-2030)
3.5.3 Europe Rheumatoid Arthritis Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rheumatoid Arthritis Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Rheumatoid Arthritis Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rheumatoid Arthritis Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Rheumatoid Arthritis Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rheumatoid Arthritis Devices Market Facts & Figures by Country
3.7.1 Latin America Rheumatoid Arthritis Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rheumatoid Arthritis Devices Sales by Country (2019-2030)
3.7.3 Latin America Rheumatoid Arthritis Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rheumatoid Arthritis Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rheumatoid Arthritis Devices Sales by Type (2019-2030)
4.1.1 Global Rheumatoid Arthritis Devices Sales by Type (2019-2024)
4.1.2 Global Rheumatoid Arthritis Devices Sales by Type (2025-2030)
4.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2030)
4.2 Global Rheumatoid Arthritis Devices Revenue by Type (2019-2030)
4.2.1 Global Rheumatoid Arthritis Devices Revenue by Type (2019-2024)
4.2.2 Global Rheumatoid Arthritis Devices Revenue by Type (2025-2030)
4.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2019-2030)
4.3 Global Rheumatoid Arthritis Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rheumatoid Arthritis Devices Sales by Application (2019-2030)
5.1.1 Global Rheumatoid Arthritis Devices Sales by Application (2019-2024)
5.1.2 Global Rheumatoid Arthritis Devices Sales by Application (2025-2030)
5.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2030)
5.2 Global Rheumatoid Arthritis Devices Revenue by Application (2019-2030)
5.2.1 Global Rheumatoid Arthritis Devices Revenue by Application (2019-2024)
5.2.2 Global Rheumatoid Arthritis Devices Revenue by Application (2025-2030)
5.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2019-2030)
5.3 Global Rheumatoid Arthritis Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Active Implants LLC
6.1.1 Active Implants LLC Corporation Information
6.1.2 Active Implants LLC Description and Business Overview
6.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Active Implants LLC Rheumatoid Arthritis Devices Product Portfolio
6.1.5 Active Implants LLC Recent Developments/Updates
6.2 Anika Therapeutics, Inc.
6.2.1 Anika Therapeutics, Inc. Corporation Information
6.2.2 Anika Therapeutics, Inc. Description and Business Overview
6.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Portfolio
6.2.5 Anika Therapeutics, Inc. Recent Developments/Updates
6.3 Arthrex, Inc.
6.3.1 Arthrex, Inc. Corporation Information
6.3.2 Arthrex, Inc. Description and Business Overview
6.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Product Portfolio
6.3.5 Arthrex, Inc. Recent Developments/Updates
6.4 Asahi Kasei Pharma Corporation
6.4.1 Asahi Kasei Pharma Corporation Corporation Information
6.4.2 Asahi Kasei Pharma Corporation Description and Business Overview
6.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Portfolio
6.4.5 Asahi Kasei Pharma Corporation Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 CONMED Corporation
6.6.1 CONMED Corporation Corporation Information
6.6.2 CONMED Corporation Description and Business Overview
6.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CONMED Corporation Rheumatoid Arthritis Devices Product Portfolio
6.6.5 CONMED Corporation Recent Developments/Updates
6.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
6.6.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
6.6.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Business Overview
6.6.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Portfolio
6.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments/Updates
6.8 Integra Lifesciences Corporation
6.8.1 Integra Lifesciences Corporation Corporation Information
6.8.2 Integra Lifesciences Corporation Description and Business Overview
6.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Portfolio
6.8.5 Integra Lifesciences Corporation Recent Developments/Updates
6.9 Johnson & Johnson (DePuy Synthes Inc.)
6.9.1 Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
6.9.2 Johnson & Johnson (DePuy Synthes Inc.) Description and Business Overview
6.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Portfolio
6.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis AG Rheumatoid Arthritis Devices Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 RTI Surgical, Inc.
6.11.1 RTI Surgical, Inc. Corporation Information
6.11.2 RTI Surgical, Inc. Rheumatoid Arthritis Devices Description and Business Overview
6.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Portfolio
6.11.5 RTI Surgical, Inc. Recent Developments/Updates
6.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
6.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
6.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Description and Business Overview
6.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Portfolio
6.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments/Updates
6.13 Setpoint Medical Corporation
6.13.1 Setpoint Medical Corporation Corporation Information
6.13.2 Setpoint Medical Corporation Rheumatoid Arthritis Devices Description and Business Overview
6.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Portfolio
6.13.5 Setpoint Medical Corporation Recent Developments/Updates
6.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
6.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
6.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Description and Business Overview
6.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Portfolio
6.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments/Updates
6.15 Stryker Corporation (OrthoSpace Ltd.)
6.15.1 Stryker Corporation (OrthoSpace Ltd.) Corporation Information
6.15.2 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Description and Business Overview
6.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Portfolio
6.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Developments/Updates
6.16 UCB Pharma S.A.
6.16.1 UCB Pharma S.A. Corporation Information
6.16.2 UCB Pharma S.A. Rheumatoid Arthritis Devices Description and Business Overview
6.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Portfolio
6.16.5 UCB Pharma S.A. Recent Developments/Updates
6.17 Zimmer Biomet
6.17.1 Zimmer Biomet Corporation Information
6.17.2 Zimmer Biomet Rheumatoid Arthritis Devices Description and Business Overview
6.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zimmer Biomet Rheumatoid Arthritis Devices Product Portfolio
6.17.5 Zimmer Biomet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rheumatoid Arthritis Devices Industry Chain Analysis
7.2 Rheumatoid Arthritis Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rheumatoid Arthritis Devices Production Mode & Process
7.4 Rheumatoid Arthritis Devices Sales and Marketing
7.4.1 Rheumatoid Arthritis Devices Sales Channels
7.4.2 Rheumatoid Arthritis Devices Distributors
7.5 Rheumatoid Arthritis Devices Customers
8 Rheumatoid Arthritis Devices Market Dynamics
8.1 Rheumatoid Arthritis Devices Industry Trends
8.2 Rheumatoid Arthritis Devices Market Drivers
8.3 Rheumatoid Arthritis Devices Market Challenges
8.4 Rheumatoid Arthritis Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rheumatoid Arthritis Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rheumatoid Arthritis Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rheumatoid Arthritis Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rheumatoid Arthritis Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rheumatoid Arthritis Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rheumatoid Arthritis Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rheumatoid Arthritis Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rheumatoid Arthritis Devices Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rheumatoid Arthritis Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rheumatoid Arthritis Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rheumatoid Arthritis Devices, Product Type & Application
Table 12. Global Key Manufacturers of Rheumatoid Arthritis Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rheumatoid Arthritis Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rheumatoid Arthritis Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rheumatoid Arthritis Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2019-2024)
Table 19. Global Rheumatoid Arthritis Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2025-2030)
Table 21. Global Rheumatoid Arthritis Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Rheumatoid Arthritis Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Rheumatoid Arthritis Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Rheumatoid Arthritis Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rheumatoid Arthritis Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rheumatoid Arthritis Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rheumatoid Arthritis Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rheumatoid Arthritis Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rheumatoid Arthritis Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rheumatoid Arthritis Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rheumatoid Arthritis Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rheumatoid Arthritis Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Rheumatoid Arthritis Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Table 53. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2025-2030)
Table 54. Global Rheumatoid Arthritis Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rheumatoid Arthritis Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Type (2019-2024)
Table 59. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Type (2025-2030)
Table 60. Global Rheumatoid Arthritis Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Rheumatoid Arthritis Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Table 63. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2025-2030)
Table 64. Global Rheumatoid Arthritis Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rheumatoid Arthritis Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Application (2019-2024)
Table 69. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Application (2025-2030)
Table 70. Active Implants LLC Corporation Information
Table 71. Active Implants LLC Description and Business Overview
Table 72. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Active Implants LLC Rheumatoid Arthritis Devices Product
Table 74. Active Implants LLC Recent Developments/Updates
Table 75. Anika Therapeutics, Inc. Corporation Information
Table 76. Anika Therapeutics, Inc. Description and Business Overview
Table 77. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product
Table 79. Anika Therapeutics, Inc. Recent Developments/Updates
Table 80. Arthrex, Inc. Corporation Information
Table 81. Arthrex, Inc. Description and Business Overview
Table 82. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Arthrex, Inc. Rheumatoid Arthritis Devices Product
Table 84. Arthrex, Inc. Recent Developments/Updates
Table 85. Asahi Kasei Pharma Corporation Corporation Information
Table 86. Asahi Kasei Pharma Corporation Description and Business Overview
Table 87. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product
Table 89. Asahi Kasei Pharma Corporation Recent Developments/Updates
Table 90. B. Braun Melsungen AG Corporation Information
Table 91. B. Braun Melsungen AG Description and Business Overview
Table 92. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product
Table 94. B. Braun Melsungen AG Recent Developments/Updates
Table 95. CONMED Corporation Corporation Information
Table 96. CONMED Corporation Description and Business Overview
Table 97. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. CONMED Corporation Rheumatoid Arthritis Devices Product
Table 99. CONMED Corporation Recent Developments/Updates
Table 100. EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
Table 101. EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Business Overview
Table 102. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product
Table 104. EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments/Updates
Table 105. Integra Lifesciences Corporation Corporation Information
Table 106. Integra Lifesciences Corporation Description and Business Overview
Table 107. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product
Table 109. Integra Lifesciences Corporation Recent Developments/Updates
Table 110. Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
Table 111. Johnson & Johnson (DePuy Synthes Inc.) Description and Business Overview
Table 112. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product
Table 114. Johnson & Johnson (DePuy Synthes Inc.) Recent Developments/Updates
Table 115. Novartis AG Corporation Information
Table 116. Novartis AG Description and Business Overview
Table 117. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novartis AG Rheumatoid Arthritis Devices Product
Table 119. Novartis AG Recent Developments/Updates
Table 120. RTI Surgical, Inc. Corporation Information
Table 121. RTI Surgical, Inc. Description and Business Overview
Table 122. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product
Table 124. RTI Surgical, Inc. Recent Developments/Updates
Table 125. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
Table 126. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Description and Business Overview
Table 127. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product
Table 129. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments/Updates
Table 130. Setpoint Medical Corporation Corporation Information
Table 131. Setpoint Medical Corporation Description and Business Overview
Table 132. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product
Table 134. Setpoint Medical Corporation Recent Developments/Updates
Table 135. Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
Table 136. Smith & Nephew plc (Osiris Therapeutics, Inc.) Description and Business Overview
Table 137. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product
Table 139. Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments/Updates
Table 140. Stryker Corporation (OrthoSpace Ltd.) Corporation Information
Table 141. Stryker Corporation (OrthoSpace Ltd.) Description and Business Overview
Table 142. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product
Table 144. Stryker Corporation (OrthoSpace Ltd.) Recent Developments/Updates
Table 145. UCB Pharma S.A. Corporation Information
Table 146. UCB Pharma S.A. Description and Business Overview
Table 147. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. UCB Pharma S.A. Rheumatoid Arthritis Devices Product
Table 149. UCB Pharma S.A. Recent Developments/Updates
Table 150. Zimmer Biomet Corporation Information
Table 151. Zimmer Biomet Description and Business Overview
Table 152. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Zimmer Biomet Rheumatoid Arthritis Devices Product
Table 154. Zimmer Biomet Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Rheumatoid Arthritis Devices Distributors List
Table 158. Rheumatoid Arthritis Devices Customers List
Table 159. Rheumatoid Arthritis Devices Market Trends
Table 160. Rheumatoid Arthritis Devices Market Drivers
Table 161. Rheumatoid Arthritis Devices Market Challenges
Table 162. Rheumatoid Arthritis Devices Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rheumatoid Arthritis Devices
Figure 2. Global Rheumatoid Arthritis Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rheumatoid Arthritis Devices Market Share by Type in 2023 & 2030
Figure 4. Implantable Joint Prostheses Product Picture
Figure 5. Spinal Devices Product Picture
Figure 6. Other Product Picture
Figure 7. Global Rheumatoid Arthritis Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Rheumatoid Arthritis Devices Market Share by Application in 2023 & 2030
Figure 9. Elderly
Figure 10. Young adults
Figure 11. Global Rheumatoid Arthritis Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Rheumatoid Arthritis Devices Market Size (2019-2030) & (US$ Million)
Figure 13. Global Rheumatoid Arthritis Devices Sales (2019-2030) & (K Units)
Figure 14. Global Rheumatoid Arthritis Devices Average Price (US$/Unit) & (2019-2030)
Figure 15. Rheumatoid Arthritis Devices Report Years Considered
Figure 16. Rheumatoid Arthritis Devices Sales Share by Manufacturers in 2023
Figure 17. Global Rheumatoid Arthritis Devices Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Rheumatoid Arthritis Devices Players: Market Share by Revenue in 2023
Figure 19. Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Rheumatoid Arthritis Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2030)
Figure 22. North America Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2030)
Figure 23. United States Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2030)
Figure 26. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2030)
Figure 27. Germany Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Rheumatoid Arthritis Devices Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Rheumatoid Arthritis Devices Revenue Market Share by Region (2019-2030)
Figure 34. China Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2030)
Figure 44. Latin America Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Rheumatoid Arthritis Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Rheumatoid Arthritis Devices by Type (2019-2030)
Figure 54. Global Revenue Market Share of Rheumatoid Arthritis Devices by Type (2019-2030)
Figure 55. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Rheumatoid Arthritis Devices by Application (2019-2030)
Figure 57. Global Revenue Market Share of Rheumatoid Arthritis Devices by Application (2019-2030)
Figure 58. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Application (2019-2030)
Figure 59. Rheumatoid Arthritis Devices Value Chain
Figure 60. Rheumatoid Arthritis Devices Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
